AR surgery guidance co Augmedics raises $36m




Israeli augmented actuality surgical procedure steering system developer Augmedics has introduced that it has raised $36 million in an over-subscribed Collection C financing spherical led by Almeda Ventures (TASE: AMDA), H.I.G. Capital and Revival Ventures and with the participation of HCA Healthcare Well being Perception Capital and XR Make investments. This newest financing spherical is barely eight months after the corporate closed a $21 million Collection B financing, and brings the whole funding up to now to $63 million. This financing spherical included additionally




RELATED ARTICLES


Augmedics  photo: PR
Israeli surgical visualization co Augmedics raises $8.3m







In December 2019, Augmedics introduced US Meals and Drug Administration (FDA) 510(ok) clearance and the launch of its xvision Backbone System (XVS) within the US. xvision is the primary and solely FDA-approved augmented actuality surgical picture steering system. The xvision Backbone System permits surgeons to visualise the 3D spinal anatomy of a affected person throughout surgical procedure as if that they had “x-ray imaginative and prescient,” and to precisely navigate devices and implants whereas wanting immediately on the affected person, somewhat than a distant display screen. The system is designed to revolutionize how surgical procedure is carried out by giving the surgeon higher visualization, management, and accuracy.
Augmedics started gross sales of xvision Backbone within the US within the second half of 2020 and closed the 12 months with over 250 spinal surgical procedures carried out with the system. The financing spherical shall be utilized by Augmedics to proceed its commercialization all through the U.S. and into OUS markets, develop the subsequent technology of merchandise, broaden to new indications, and procure CE certification for gross sales in Europe.
“We’re more than happy to have accomplished this huge financing spherical led by H.I.G. Capital, Revival Healthcare Capital, and Almeda Ventures, which is able to allow us to advertise and broaden our operations and meet the sturdy demand we’re experiencing for our know-how within the U.S. following our industrial launch final 12 months,” mentioned Nissan Elimelech, CEO and founding father of Augmedics.
Almeda Ventures is a public restricted partnership investing in healthcare R&D firms, headed by Tzahi Sultan, Irit Yaniv, and Amir Blatt. Since its institution in 2020 the fund has invested in six firms.
Revealed by Globes, Israel enterprise information – en.globes.co.il – on March 30, 2021
© Copyright of Globes Writer Itonut (1983) Ltd. 2021



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *